Digital Ulcers: Multidisciplinary Approach and Dermatological Management
Keywords:
digital ulcer, multidisciplinary approach, dermatology, ischaemic wound, dressingAbstract
Introduction: Digital ulcers represent a current public health issue, due to the relevant difficulties in their management and their tendency to become chronic, non-healing lesions.
We present an observational study of 28 patients referred to our Wound Care Service, focused on multidisciplinary and dermatological management.
Objectives: Our case series represents an opportunity to discuss the main comorbidities that affect these kinds of patients and to present an evidence-based protocol that has proved highly effective in our clinical practice.
Methods: We collected the clinical data of 28 patients referred to our Wound Care Service at S.Orsola-Malpighi Hospital, where they were all clinically evaluated; subsequently a local treatment was set up with dressings and the application of topical medications, while for most of them a further multidisciplinary evaluation was required to control the underlying disease and to avoid relapses.
Results: Digital ulcers were divided into 5 categories, based on the causative agent: peripheral artery disease, diabetes associated wounds, mixed wounds, pressure wounds and immune-mediated diseases associated with wounds. Each group received a specific management, based on the characteristics of the ulcer and the underlying comorbidities.
Conclusions: The clinical evaluation of digital wounds requires a thorough knowledge of the possible causes behind the onset of these ulcerative forms. In case of suspicion, send the patient for a specialist evaluation, to carry out a proper management of the case. A multidisciplinary approach in the management of these wounds is necessary to achieve a precise diagnosis and a correct treatment.
References
Criqui MH, Fronek A, Barrett-Connor E, Klauber MR, Gabriel S, Goodman D. The prevalence of peripheral arterial disease in a defined population. Circulation. 1985;71(3):510-515. doi:10.1161/01.CIR.71.3.510
Ricco JB, Bartelink MLEL. Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries Endorsed by: the European Stroke Organization (ESO). :60.
Sibbald RG, Elliott JA, Persaud-Jaimangal R, et al. Wound Bed Preparation 2021. Adv Skin Wound Care. 2021;34(4):183-195. doi:10.1097/01.ASW.0000733724.87630.d6
Hajhosseini B, Longaker MT, Gurtner GC. Pressure Injury. Annals of Surgery. 2020;271(4):671-679. doi:10.1097/SLA.0000000000003567
Chioncel V, Brezeanu R, Sinescu C. New Directions in the Management of Peripheral Artery Disease. American Journal of Therapeutics. 2019;26(2):e284-e293. doi:10.1097/MJT.0000000000000916
Hinchliffe RJ, Forsythe RO, Apelqvist J, et al. Guidelines on diagnosis, prognosis, and management of peripheral artery disease in patients with foot ulcers and diabetes (IWGDF 2019 update). Diabetes Metab Res Rev. 2020;36(S1). doi:10.1002/dmrr.3276
Chan KA, Junia A. Lower extremity peripheral artery disease: a basic approach. Br J Hosp Med. 2020;81(3):1-9. doi:10.12968/hmed.2019.0263
Khan NA, Rahim SA, Anand SS, Simel DL, Panju A. Does the Clinical Examination Predict Lower Extremity Peripheral Arterial Disease? :11.
Gerhard-Herman MD, Gornik HL, Barrett C, et al. 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2017;135(12). doi:10.1161/CIR.0000000000000470
Hennion DR, Siano KA, Center TAM. Diagnosis and Treatment of Peripheral Arterial Disease. Peripheral Arterial Disease. 2013;88(5):5.
Morley RL, Sharma A, Horsch AD, Hinchliffe RJ. Peripheral artery disease. BMJ. Published online February 1, 2018:j5842. doi:10.1136/bmj.j5842
Selvin E, Erlinger TP. Prevalence of and Risk Factors for Peripheral Arterial Disease in the United States: Results From the National Health and Nutrition Examination Survey, 1999–2000. Circulation. 2004;110(6):738-743. doi:10.1161/01.CIR.0000137913.26087.F0
Khan S, Flather M, Mister R, et al. Characteristics and Treatments of Patients with Peripheral Arterial Disease Referred to UK Vascular Clinics: Results of a Prospective Registry. European Journal of Vascular and Endovascular Surgery. 2007;33(4):442-450. doi:10.1016/j.ejvs.2006.11.010
Boulton AJ, Vileikyte L, Ragnarson-Tennvall G, Apelqvist J. The global burden of diabetic foot disease. The Lancet. 2005;366(9498):1719-1724. doi:10.1016/S0140-6736(05)67698-2
Morris AD, McAlpine R, Steinke D, et al. Diabetes and Lower-Limb Amputations in the Community: A retrospective cohort study. Diabetes Care. 1998;21(5):738-743. doi:10.2337/diacare.21.5.738
Brem H, Sheehan P, Rosenberg HJ, Schneider JS, Boulton AJM. Evidence-Based Protocol for Diabetic Foot Ulcers: Plastic and Reconstructive Surgery. 2006;117(SUPPLEMENT):193S-209S. doi:10.1097/01.prs.0000225459.93750.29
Brem H. Healing of Diabetic Foot Ulcers and Pressure Ulcers With Human Skin Equivalent: A New Paradigm in Wound Healing. Arch Surg. 2000;135(6):627. doi:10.1001/archsurg.135.6.627
Mostow EN. Diagnosis and classification of chronic wounds. Clinics in Dermatology. 1994;12(1):3-9. doi:10.1016/0738-081X(94)90251-8
Rodrigues TC, Pecis M, Azevedo MJ, Gross JL. Homeostase pressórica e complicações microvasculares em pacientes diabéticos. Arq Bras Endocrinol Metab. 2005;49(6):882-890. doi:10.1590/S0004-27302005000600005
Elgzyri T, Larsson J, Nyberg P, Thörne J, Eriksson KF, Apelqvist J. Early Revascularization after Admittance to a Diabetic Foot Center Affects the Healing Probability of Ischemic Foot Ulcer in Patients with Diabetes. European Journal of Vascular and Endovascular Surgery. 2014;48(4):440-446. doi:10.1016/j.ejvs.2014.06.041
Colagiuri S, Marsden LL, Naidu V, Taylor L. The use of orthotic devices to correct plantar callus in people with diabetes. Diabetes Research and Clinical Practice. 1995;28(1):29-34. doi:10.1016/0168-8227(95)01050-N
Mervis JS, Phillips TJ. Pressure ulcers: Prevention and management. Journal of the American Academy of Dermatology. 2019;81(4):893-902. doi:10.1016/j.jaad.2018.12.068
Jaul E. Cohort study of atypical pressure ulcers development: Atypical pressure ulcers development. Int Wound J. 2014;11(6):696-700. doi:10.1111/iwj.12033
Trompetto C, Marinelli L, Mori L, et al. Pathophysiology of Spasticity: Implications for Neurorehabilitation. BioMed Research International. 2014;2014:1-8. doi:10.1155/2014/354906
Reddy M, Gill SS, Rochon PA. Preventing Pressure Ulcers: A Systematic Review. JAMA. 2006;296(8):974. doi:10.1001/jama.296.8.974
Grey JE, Harding KG, Enoch S. Pressure ulcers. BMJ. 2006;332(7539):472-475. doi:10.1136/bmj.332.7539.472
Gould L, Stuntz M, Giovannelli M, et al. Wound healing society 2015 update on guidelines for pressure ulcers: Guidelines for the treatment of pressure ulcers. Wound Rep and Reg. 2016;24(1):145-162. doi:10.1111/wrr.12396
Boyko TV, Longaker MT, Yang GP. Review of the Current Management of Pressure Ulcers. Advances in Wound Care. 2018;7(2):57-67. doi:10.1089/wound.2016.0697
Singer AJ, Tassiopoulos A, Kirsner RS. Evaluation and Management of Lower-Extremity Ulcers. Campion EW, ed. N Engl J Med. 2017;377(16):1559-1567. doi:10.1056/NEJMra1615243
Costedoat I, Masson M, Barnetche T, et al. Locoregional Treatments for Digital Ulcers in Systemic Sclerosis: A Systematic Review. Acta Derm Venereol. 2021;101(6):adv00478. doi:10.2340/00015555-3839
Denton CP, Khanna D. Systemic sclerosis. The Lancet. 2017;390(10103):1685-1699. doi:10.1016/S0140-6736(17)30933-9
Nihtyanova SI, Brough GM, Black CM, Denton CP. Clinical burden of digital vasculopathy in limited and diffuse cutaneous systemic sclerosis. Annals of the Rheumatic Diseases. 2008;67(1):120-123. doi:10.1136/ard.2007.072686
Allanore Y, Denton CP, Krieg T, et al. Clinical characteristics and predictors of gangrene in patients with systemic sclerosis and digital ulcers in the Digital Ulcer Outcome Registry: a prospective, observational cohort. Ann Rheum Dis. 2016;75(9):1736-1740. doi:10.1136/annrheumdis-2016-209481
Mihai C, Landewé R, van der Heijde D, et al. Digital ulcers predict a worse disease course in patients with systemic sclerosis. Ann Rheum Dis. 2016;75(4):681-686. doi:10.1136/annrheumdis-2014-205897
Khanna D, Denton CP, Merkel PA, et al. Effect of Macitentan on the Development of New Ischemic Digital Ulcers in Patients With Systemic Sclerosis: DUAL-1 and DUAL-2 Randomized Clinical Trials. JAMA. 2016;315(18):1975. doi:10.1001/jama.2016.5258
Domsic RT, Nihtyanova SI, Wisniewski SR, et al. Derivation and Validation of a Prediction Rule for Two-Year Mortality in Early Diffuse Cutaneous Systemic Sclerosis: A Validated Two-Year Mortality Model for Early Diffuse Scleroderma. Arthritis & Rheumatology. 2014;66(6):1616-1624. doi:10.1002/art.38381
Dabiri G, Falanga V. Connective tissue ulcers. Journal of Tissue Viability. 2013;22(4):92-102. doi:10.1016/j.jtv.2013.04.003
Danning CL, lllei GG, Boumpas DT. Vasculitis associated with primary rheumatologic diseases: Current Opinion in Rheumatology. 1998;10(1):58-65. doi:10.1097/00002281-199801000-00009
Hirche D, Rubbert A, Lunau L, Krieg T, Eming SA. Successful treatment of refractory rheumatoid arthritis-associated leg ulcerations with adalimumab. Br J Dermatol. 2005;152(5):1062-1064. doi:10.1111/j.1365-2133.2005.06520.x
Öien RF, Håkansson A, Hansen BU. Leg ulcers in patients with rheumatoid arthritis—a prospective study of aetiology, wound healing and pain reduction after pinch grafting. Rheumatology. 2001;40(7):816-820. doi:10.1093/rheumatology/40.7.816
Goslen JB. Autoimmune ulceration of the leg. Clinics in Dermatology. 1990;8(3-4):92-117. doi:10.1016/0738-081X(90)90050-B
Fink AM, Kottas-Heldenberg A, Mayer W, et al. Lupus anticoagulant and venous leg ulceration. Br J Dermatol. 2002;146(2):308-310. doi:10.1046/j.0007-0963.2001.04546.x
Published
Issue
Section
License
Copyright (c) 2022 Michela Starace, Gionathan Orioni, Aurora Alessandrini, Francesca Bruni, Carlotta Baraldi, Cosimo Misciali, Bianca Maria Piraccini
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Dermatology Practical & Conceptual applies a Creative Commons Attribution License (CCAL) to all works we publish (http://creativecommons.org/licenses/by-nc/4.0/). Authors retain the copyright for their published work.